All lobbying filings

THORN RUN PARTNERS

Lobbying for PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Compounding Pharmacy Supplier/Provider

Filing 1st Quarter - Termination

1st Quarter (Jan 1 - Mar 31) 2025 · Texas · House · Senate · $30,000.00 income · posted Apr 17, 2025

Official filing document

Bills named in this filing 2

HR 167
Patient Access to Urgent-Use Pharmacy Compounding Act of 2023
HR 3810
Drug Origin Transparency Act of 2023

Lobbying activity 3

Health Issues

Issues related to drug supply chain and drug shortages. Issues related to bioidentical compounded hormones.

Pharmacy

Issues related to the Drug Quality and Security Act, Compounding Pharmacy, Reimbursement, and Patient Access, animal compounding, and H.R.167 - Patient Access to Urgent-Use Pharmacy Compounding Act of 2023. H.R.3810 - Drug Origin Transparency Act of 2023.

Medicare/Medicaid

Medicare Part D reimbursement of bulk substances.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.